First human test of new cholesterol drug begins
NCT ID NCT06727396
Summary
This early-stage study tested the safety and how the body processes an experimental drug called CKD-508 in healthy volunteers. Forty-four healthy adults received either the drug or a placebo to check for side effects and measure how the drug moves through the body. Researchers also looked at early signs of whether the drug might affect cholesterol levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Glendale, California, 91206, United States
Conditions
Explore the condition pages connected to this study.